ArticlePolymers2026
Fracture Toughness and Failure Mechanisms of Glass-Reinforced Plastics Based on an Epoxy Matrix Modified with Polysulfone and an Active Diluent.
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The crack resistance of unidirectional fiberglass-reinforced plastics based on an epoxy matrix modified with polysulfone (PSU) and furfuryl glycidyl ether (FGE) was investigated. The combined addition of PSU/FGE modifiers to the epoxy matrix increases the crack resistance of glass-fiber-reinforced plastics (GFRPs). The effect of increasing the crack resistance of GFRPs varies depending on the modifier ratio. The greatest increase in crack resistance is achieved with a modifier ratio of 1/0.5. For this ratio, the value of GIRCM is 1.18 kJ/m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.